Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 从事生物药物研究开发生产的CDMO公司

迈百瑞国际生物医药股份有限公司,成立于2013年6月,座落于中国北方美丽的滨海城市烟台,*期工程占地68亩,建筑面积23000平方米。这里依山傍海,风景秀丽,气候宜人,空气清新,是生物医药生产研发的理想之地。 迈百瑞公司致力于提供高质量的生物药物研发和GMP生产一站式外包服务,满足客户研发和GMP生产需求,加快生物药物的研发速度。迈百瑞的独特优势,不仅体现在提供单克隆抗体药物研发过程中从细胞系开发到大规模GMP生产的全方位服务,而且提供抗体-药物偶联(ADC)药物研发过程中从细胞毒素合成、链接子生产到偶联的全过程解决方案。迈百瑞为客户提供大规模(2000L细胞培养)单抗生产、商业化规模的ADC偶联药品制备服务。从工艺开发到大规模的GMP生产,迈百瑞领行业之先;ADC偶联药品的大规模生产,迈百瑞夺亚洲之冠。 迈百瑞拥有国际一流的生物医药研发和运营管理团队。团队核心成员均来自国际大型生物制药企业及一流生物实验室,拥有二十多年大分子生物新药研发、GMP生产领域丰富经验。 迈百瑞秉承以客户为中心的理念,依托细胞系开发、蛋白质药物大规模表达、纯化、制剂、抗体-小分子毒物偶联等关键技术,凭借CHO、ADC两个生物新药创制技术平台,为全球客户提供单克隆抗体、重组蛋白、抗体药物偶联等一系列生物药物研发及生产外包服务,通过高效率、高性价比、高质量的外包服务帮助客户缩短研发周期,降低大分子生物药物研制成本,为生物新药产品研发提供*尖端的专业支持。 迈百瑞公司建立了符合欧美及中国GMP管理标准的质量管理体系,致力于保障生产厂房和相关设施严格按照美国FDA、欧盟EMA、中国CFDA的GMP管理要求建立和运营。可以有效地支持在中国、美国、及欧洲的新药临床申报、临床试验、以及商业化过程中的药物生产。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

迈百瑞 Financing History (1 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 4亿人民币
  • Investor: 国投创业,深创投

迈百瑞 How Fast Is Hiring Growing? (6 open positions)

Manage
Note: How fast is hiring at 烟台迈百瑞国际生物医药股份有限公司 growing? 迈百瑞2025: 18 openings (up 20%), 2024: 15 openings (down 38%), 2023: 24 openings (down 25%), 2022: 32 openings (up 100%), 2021: 16 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

迈百瑞 Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
迈百瑞 Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 烟台迈百瑞国际生物医药股份有限公司 growing? 迈百瑞Master's recruitment over the years: 2026: 6 openings (down 39%), 2024: 6 openings (down 38%), 2023: 9 openings (down 25%), 2022: 12 openings (up 100%), 2021: 8 openings.

迈百瑞 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
迈百瑞 Doctoral Hiring by Year: 2024 — 6 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 烟台迈百瑞国际生物医药股份有限公司 growing? 迈百瑞Doctorate recruitment over the years: 2024: 2 openings (down 38%), 2023: 8 openings (down 25%), 2022: 9 openings (up 100%), 2021: 1 openings.

迈百瑞 — What Are the Salaries Like? (13 records)

Manage
迈百瑞 Salary Overview
salary range: 6K - 15K, 92.3% of roles pay ¥6-10K
Note: salary statistics are based on 13 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 烟台迈百瑞国际生物医药股份有限公司?迈百瑞92.3% of positions earn 6-10K, Undergraduate salary: ¥。生物/制药/化工/环保类 average salary ¥8.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

迈百瑞 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

迈百瑞 Related Industry Tags

Job Category

  • 生物/制药/化工/环保类
    61.5% of total 61.5%
  • 技工类
    53.8% of total 53.8%
  • 其他(研发和技术类)
    46.2% of total 46.2%
  • 科研类
    46.2% of total 46.2%

Education

  • 硕士
    46.2% of total 46.2%
  • 本科
    46.2% of total 46.2%
  • 大专
    7.7% of total 7.7%

Experience

  • 1-3年
    69.2% of total 69.2%
  • 不限
    30.8% of total 30.8%
View Detailed Analysis

What does 烟台迈百瑞国际生物医药股份有限公司 require? Who is 迈百瑞 hiring? 迈百瑞 recruitment: 生物/制药/化工/环保类占比最多占61.5%,其次是技工类占53.8%. What education can get in at 迈百瑞? 硕士占比最多占46.2%,其次是本科占46.2%. High education required at 迈百瑞? 硕士占46.2%. Work experience required at 迈百瑞? 1-3年占比最多占69.2%,其次是不限占30.8%. Where are the job locations at 迈百瑞? 烟台占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 40,440.7116万(元)
Legal Representative: 房健民
Date Established:
Credit Code: 9137060007302939X9
Registered Address: 中国(山东)自由贸易试验区烟台片区烟台开发区北京中路60号

Partners & Suppliers

为乐普生物提供ADC药物的CDMO服务 Source
合作客户 生物药CDMO服务
利穗科技向迈百瑞提供纯化设备,支持其CDMO服务 Source
供应商 生物制药CDMO
采购其生物分离纯化介质(层析填料) Source
供应商 生物制药
提供疫苗生产用细胞培养基 Source
合作客户 原辅料供应商
提供细胞培养基 Source
供应商 培养基

People who follow 迈百瑞 also follow

迈百瑞 Competitors (Similar Companies)

“A modern pharmaceutical enterprise spanning three major fields: modern”
“Customer-oriented, Efficient operations, Empower employees”
“Research and development of new drugs for major diseases such as malig”
“To become a world-class chemical new materials company with global ope”
“生化原料药生产”
“National Innovative Demonstration Enterprise for Pharmaceutical Distri”
“Improve the quality of life of the people, enhance the level of social”
医药 生物医药 生物制药 胰岛素
“Provides bioscience and technology solutions”
医药中间体 化学合成 化合物设计合成 实业投资
生物医药 医药 医疗科技 医药科技
“高性能纤维研发生产基地”
制药/药业 医药 原料药 植物提取
电子厂/电子 电子技术
生物医药 原料药 化学制药 糖浆剂

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates